Finance Monthly Deal Maker Awards 2019 Edition

www.finance-monthly.com 36 FINANCE MONTHLY DEAL MAKER AWARDS 2019 INITIAL PUBLIC OFFERING DR. IVOR ELRIFI Partner at Cooley LLP ABOUT DR. IVOR ELRIFI Dr. Ivor Elrifi is the chair of Cooley’s patent counseling and prosecution practice group. He advises pharmaceutical, biotechnology, life sciences and medical device companies, research institutions, universities, hospitals and governments throughout the world, particularly in the US and Europe. His practice includes patent prosecution, litigation, arbitration, licensing and transactional work with a focus on novel therapeutic treatments, biotechnology, genetics, diagnostics, biomarkers, drug formulations and medical devices. Ivor counsels clients worldwide in developing and implementing patent strategies and in the prosecution, licensing and enforcement of patents. He has extensive experience in advising clients on transactional work and regularly counsels clients with respect to investments, mergers and acquisitions. He has also advised plaintiffs and defendants in patent litigation and arbitration cases. Ivor is widely recognized as one of the top life sciences patent lawyers in the world by numerous prominent legal directories and publications. In 2018, he was singled out as the “Patent Strategy & Management Attorney of the Year” by LMG Life Sciences (he also won the award in 2016). In addition, year after year, including 2018, he has been named a “Life Sciences Star” by LMG Life Sciences, an “IP Star” by Managing Intellectual Property, a leading patent lawyer by IAM Patent 1000, recognized as one of the world’s leading experts on patent law by Euromoney, and named a leader in IP law by Chambers, Legal 500 and Super Lawyers. Prior to joining Cooley, Ivor was co-chair and section manager of Mintz Levin’s intellectual property practice and a member of the firm’s management committee. Earlier in his career, he served as patent counsel and then general counsel and vice president for CytoTherapeutics in Providence, Rhode Island, and as patent counsel to Modex Therapeutics in Lausanne, Switzerland. He has spoken at numerous international conferences, and he has written numerous articles for leading legal and scientific publications. Recent matters include: • Outside patent counsel for a global diagnostics/healthcare company in prosecuting numerous patents that cover emulsion PCR and massively parallel nucleic acid sequencing technology. • Outside patent counsel for a global healthcare company in prosecuting to issuance numerous patents for an oncology drug, the first in class FDA-approved HDAC inhibitor for the treatment of cancer. • Lead patent counsel in the acquisition of a US-based biotechnology to a global pharma company in a deal valued in excess of $8 billion. Areas of Expertise: • Intellectual Property • Patent Counseling & Prosecution – Life Sciences • Patent Office Litigation • Life Sciences IP Litigation • Life Sciences • Medtech • Israel Awarded for his involvement in the following transaction: Cooley Advises on Nightstar + NuCana IPOs CONTACT Ivor Elrifi E: ielrifi@cooley.com W: www.cooley.com FIRM PROFILE Founded in 1920, Cooley LLP is an American international law firm, particularly known for its market-leading technology and life sciences practices as well as its vast experience with initial public offerings (IPOs), venture capital connections & financings. Cooley LLP has 13 offices across the United States, China and Europe and employs 900+ Lawyers, 300 + partners in a single-tier global partnership and 2000+ people worldwide. They were recognised as a Fortune 100 Best Companies to Work For. Practices: • Corporate • Litigation • Regulatory • Intellectual Property Industries • Technology • Life Sciences & Healthcare • Communications & Media • Education